Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VAMP3 | CTRPv2 | pan-cancer | AAC | -0.23 | 5e-08 |
mRNA | PARP1 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
mRNA | POLR2D | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | HMGB1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | HNRNPA1L2 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-08 |
mRNA | DTL | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | RANBP3 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | RFXAP | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
mRNA | RNGTT | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |